Prenatal karyotype analysis in high risk families.
D000619:Aminohydrolases / Q000032:analysis; D000649:Amniocentesis; D000653:Amniotic Fluid / Q000032:analysis / Q000166:cytology; D001224:Aspartic Acid / Q000032:analysis; D002478:Cells, Cultured; D002869:Chromosome Aberrations / Q000175:diagnosis / Q000235:genetics*; D025063:Chromosome Disorders; D002901:Chromosomes, Human, 13-15; D002903:Chromosomes, Human, 19-20; D002904:Chromosomes, Human, 21-22 and Y; D005260:Female; D005944:Glucosamine / Q000032:analysis; D006801:Humans; D007621:Karyotyping; D008423:Maternal Age; D008661:Metabolism, Inborn Errors / Q000235:genetics; D008875:Middle Aged; D011247:Pregnancy; D011296:Prenatal Diagnosis; D013194:Staining and Labeling; D014314:Trisomy
D001224:Aspartic Acid; D000619:Aminohydrolases; D005944:Glucosamine